Health & Beauty

About 350 companies from 33 countries and regions participated in the exhibition, the world's top 500 and industry leading companies exceeded 70, the special decoration rate of the exhibition area exceeded 97%, and the first exhibition of various new products and new technologies... in the 4th China International Import At the expo, the medical equipment and medicine and health care exhibition area was further expanded and upgraded. Many multinational companies have expressed their optimism about the huge market of China's health industry and the opportunities brought by China's open development.

u3000u3000 It is worth noting that improving the health of the whole people, strengthening public health cooperation among countries, and jointly building a human health and health community have also become important topics of the CIIE. In the sub-forum of the 4th Hongqiao International Economic Forum "National Health and the Harmonious Development of Economy and Society: New Ideas and New Kinetic Energy", experts and entrepreneurs participating in the forum discussed in depth and believed that facing the challenge of the new crown pneumonia epidemic, global cooperation must be further strengthened to jointly respond In order to promote the development of human health through innovation, the active role of traditional Chinese medicine and digital technology must also be brought into play.

u3000u3000The health awareness of the whole people is further strengthened

u3000u3000The epidemic has further strengthened the health awareness of the whole society. Zhong Nanshan, academician of the Chinese Academy of Engineering, said in a video speech at the forum that the new crown pneumonia epidemic has caused a great change in the society's concept of disease and health. A survey shows that 93% of people believe that the most important thing in life is "physical health", and 74% of respondents have changed their outlook on life because of the epidemic.

u3000u3000 "It can be seen that the epidemic has accelerated and improved the formation and development of the national health awareness." Zhong Nanshan said.

u3000u3000 Zhang Yuntao, chief scientist and vice president of China National Biotechnology Co., Ltd., pointed out that the global spread of new coronary pneumonia has made us more aware of the importance of facing public health issues globally. In the face of the epidemic, it is impossible for anyone or any country to survive alone. In particular, major new and sudden infectious diseases pose severe challenges to the international order and human survival.

u3000u3000 Zhang Yuntao suggested that the world should actively carry out public health cooperation and jointly build a human health and health community, maintain the global public health order, and ensure the survival and health of mankind.

u3000u3000 Not only that, but promoting the health of the whole people is also an important guarantee for economic and social development. The "Outline of the "Healthy China 2030" Plan" proposes that health is an inevitable requirement for the promotion of all-round human development and a basic condition for economic and social development. Achieving people’s health and longevity is an important symbol of the country’s prosperity and national rejuvenation, and it is also the common aspiration of the people of all ethnic groups across the country.

u3000u3000 In response to the current situation, Zhong Nanshan believes that the global epidemic situation is still severe, and relevant scientific research and prevention efforts still need to be made. Only by ensuring the balance between national health and economic development can we achieve a high-quality cycle between economy and health. Zhang Yuntao also said that health is an eternal topic of mankind, is the foundation of the comprehensive and sustainable development of society, and a sign of the progress of human civilization.

Jean-Pierre Michel, chairman of the European Interdisciplinary Committee on Aging, analyzed the relationship between economics and life expectancy. He proposed that increasing life expectancy increases the labor force and at the same time economic development creates better conditions for medical services. This relationship exists in any country in the world.

u3000u3000All sectors work together to promote the development of the health industry

u3000u3000 On the basis of forming a consensus, the participants also offered suggestions one after another, and gathered forces from all walks of life to further promote the development of human health.

Li Ling, director of the China Center for Health Development Research of Peking University, said at the forum that in this fight against the epidemic, we can see that public hospitals are a reliable guarantee for maintaining people’s health. We must continue to promote the high-quality development of public hospitals and provide public Three recommendations for hospital development: one is high-quality output, which should serve a healthy China strategy, rather than pure and sophisticated treatment; the other is high-quality services, providing comprehensive services ranging from prevention to health management to treatment to rehabilitation. , Health management throughout the life cycle; third is the allocation of high-quality resources to improve the ratio of resources for prevention.

u3000u3000 Li Ling also pointed out that the application of information technology such as traditional Chinese medicine and big data in the field of biomedicine has performed well in the fight against the epidemic. "Integrating these positive factors, we have the hope to create a Chinese solution for human health."

u3000u3000 Ding Yongling, deputy general manager of Beijing Tongrentang (Group) Co., Ltd., also said that in this health crisis that affects all mankind, the positive role of Chinese medicine has been known to the world. She believes that this is a major strategic opportunity for Chinese medicine to further expand into the world.

u3000u3000 Ding Yongling suggested that the next step is to continue to seize the opportunity and vigorously spread the culture of Chinese medicine, so that the world can better understand Chinese medicine, choose Chinese medicine, and contribute Chinese wisdom and Chinese solutions to human health.

u3000u3000 Zhong Nanshan emphasized that the rapidly developing digital technology has played a very important role in the prevention and control of this epidemic. Big data and artificial intelligence have greatly improved the diagnosis, prediction and treatment of new coronary pneumonia, and also provided an important basis for policy formulation. Internet medical care also played an important role during the epidemic.

Zhong Nanshan proposed that health science and technology innovation should continue to be promoted, including building a national medical science and technology innovation system, strengthening the capacity building of scientific research institutions, strengthening cutting-edge medical technology, focusing on key areas such as precision medicine and smart medical care, and strengthening scientific and technological support for the development of the health industry ability.

u3000u3000 In fact, this is also the key support direction of the policy. The "Healthy China 2030" Planning Outline takes reform and innovation as the main principles to follow, and proposes to adhere to the government's leadership, give play to the role of market mechanisms, accelerate the pace of reforms in key links, break through the constraints of ideological concepts, remove barriers to solidification of interests, remove institutional barriers, and make use of science and technology The leading and supporting role of innovation and informatization will form an institutional system with Chinese characteristics that promotes the health of the whole people.

u3000u3000The analysis pointed out that as the system becomes more mature, technical support is more stable, and all parties advance together, my country's medical and health industry is expected to enter a period of rapid development.

u3000u3000 Multinational companies increase R&D investment in the Chinese market

u3000u3000 The huge market and development speed of China's health industry and China's emphasis on innovation and development have further strengthened the determination of multinational companies to increase their development. This can be seen from the scene of the CIIE.

In the 70,000 square meters of medical equipment and medical care exhibition area, the world's top three companies in the oral industry, the world's three top radiotherapy giants, the three major genetic testing companies, the global kidney giants, etc., gather together, Abbott’s new-generation cardioversion defibrillator After its debut in China, Johnson & Johnson's electronic bronchoscopy surgical robot will make its Asian debut, and its new products and technologies will far exceed the previous three times.

u3000u3000 These companies have also made it clear that they will increase R&D investment in the Chinese market.

u3000u3000 Wang Lei, AstraZeneca’s Global Executive Vice President and President of International Business and China, said at the forum that China’s new drug R&D is overtaking in a curve. "In the future, in the foreseeable 3 to 5 years, we will see many world-first drugs being marketed first in China, and it is entirely possible for China to catch up in innovative medicine in 5 to 10 years," he said.

u3000u3000 Wang Lei said that as a multinational company, AstraZeneca attaches great importance to China's innovation environment.

u3000u3000 Previously, AstraZeneca had upgraded the existing Shanghai R&D platform to AstraZeneca’s global R&D China center. The center was opened on the eve of the current CIIE. The company's regional headquarters in Wuxi, Beijing, Hangzhou, and Chengdu have also been opened, and the regional headquarters in Guangzhou will soon be completed and opened in November this year.

u3000u3000 AstraZeneca is just a microcosm, and there are more multinational pharmaceutical companies optimistic about the development prospects of China's health industry. Peng Zhenke, President of Pfizer Biopharmaceutical Group China, said that in the future, China will lead the world in pharmaceutical innovation. Pfizer will strengthen cooperation with local Chinese biotechnology companies, jointly invent and commercialize, and jointly bring these products to the market.

u3000u3000Siemens Healthcare Greater China President Wang Hao said that China has become the world's second largest market for Siemens Healthcare. Siemens Healthcare will continue to participate in the CIIE next year, continue to increase investment in innovation and localized R&D, and jointly build a healthcare ecosystem.

Exhibitors also expressed that with the normalization of the global epidemic, high-quality innovation cooperation at home and abroad is becoming more and more important. The CIIE will undoubtedly provide an excellent platform for exchanges and cooperation in the world pharmaceutical industry, and look forward to co-creating more with more partners Many breakthrough products and services contribute to the health of all mankind.